Sophie Hill
Family Medicine · Lufkin, TXNPI 1083113534
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.
Across 251 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$814
- AstraZeneca$674
- Novo Nordisk$619
- Bayer$597
- Lilly USA, LLC$542
- Boehringer Ingelheim$305
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,77099%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $814 |
| AstraZeneca | 28 | $674 |
| Novo Nordisk | 37 | $619 |
| Bayer | 27 | $597 |
| Lilly USA, LLC | 36 | $542 |
| Boehringer Ingelheim | 14 | $305 |
| Amgen | 8 | $183 |
| Medtronic | 2 | $172 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $165 |
| GSK | 5 | $110 |
| Pfizer | 5 | $88 |
| Jazz Pharmaceuticals Inc. | 3 | $77 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Exeltis, USA Inc. | 2 | $44 |
| Acella Pharmaceuticals, LLC | 2 | $36 |
| Antares Pharma, Inc. | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Kaleo, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Abbott | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Merck | 1 | $12 |
| Eisai Inc. | 1 | $11 |
How this compares
$4,797 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 14 | $538 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lufkin
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.